Treating peripheral lung tumours with SABR

Diagnosis and treatment in rare cases of thymoma

Next wave of successful drug therapy strategies in HER2-positive breast cancer

The sub-typing of lung cancer and squamous cell carcinoma

Treatment of non-small cell lung cancer and adenocarcinoma

Treating adenocarcinoma with bevacizumab

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Implementation of individualised treatment and the WINTHER trial

Importance of personalised medicine and the WIN Consortium

Achievements of the WIN Consortium